EAU 2013 - Programme Book - YouMed

Sunday
Sunday, 17 March - EAU Programme
194 Programme Book
Abstract Session
14.00 - 15.30 How to optimise staging in prostate cancer?
Brown Hall 1-2 - Level S2
Poster Session 39
Chairs: C.B. Congregado Ruiz, Sevilla (ES)
H-P. Schmid, St. Gallen (CH)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
* 465 High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) topographical distribution in 1374 prostate
specimens: Existence of topographical relationship between prostate cancer and HGPIN
O. Eminaga, R. Hinkelammert, E. Eltze, O. Bettendorf, U. Titze, A. Semjonow (Cologne, Muenster,
Saarbruecken, Schüttorf, Germany)
466 Clinical significance of benign prostatic tissue at the soft tissue margin in robotic and open radical
prostatectomy
S. Park, M. Shim, D. Yoo, C. Song, C-S. Kim, H. Ahn (Seoul, South Korea)
467 Are the efforts towards prostate cancer early detection associated with a significant reduction in tumor
volume? An analysis stratified according to risk categories
N. Suardi, A. Gallina, U. Capitanio, M. Tutolo, N. Fossati, R. Matloob, A. Russo, A. Salonia, R. Bertini, V. Di
Girolamo, M. Freschi, C. Doglioni, G. Guazzoni, A. Briganti (Milan, Italy)
* 468 Cancer volume is an independent predictor for biochemical progression and clinical failure in high-risk
prostate cancer patients following radical prostatectomy: A single centre experience
L. Hakim, M. Spahn, P. Gontero, S. Van Bruwaene, A. Briganti, C.Y. Hsu, K. Jeffrey, S. Joniau (Leuven,
Belgium; Berne, Switzerland; Milan, Italy; Puli, Taiwan; Rochester, United States of America)
469 Impact of statin use on biochemical recurrence after radical prostatectomy for prostate cancer
S. Park, M. Shim, D. Yoo, J. Kim, C. Song, J.H. Hong, C-S. Kim, H. Ahn (Seoul, South Korea)
470 Simple prediction model of side-specific extracapsular extension based on percent positive biopsy cores
and tumor contact length with the capsule on MRI
Y. Matsuoka, J. Ishioka, N. Numao, H. Tanaka, S. Yoshida, M. Yokoyama, F. Koga, K. Saito, H. Masuda,
Y. Fujii, K. Kihara (Tokyo, Japan)
* 471 Risk stratification among men undergoing radical prostatectomy for high-risk prostate cancer in a US
cohort: An EMPaCT validation study
J. Karnes, A. Briganti, P. Gontero, M. Spahn, S. Joniau (Rochester, United States of America; Milan, Turin,
Italy; Berne, Switzerland; Leuven, Belgium)
472 Laparoscopic sentinel lymph node (SLN) dissection correlated to extended pelvic lymph node dissection for
clinically localized prostate cancer (PC): 200 patients
T.G.M. Rousseau, J. Lacoste, E. Potiron, G. Le Coguic, G. Aillet, M. Lacombe, L. Campion, C. Rousseau (Saint
Herblain, Nantes, France)
* 473 Pathological nodal staging score for prostate cancer: A tool to address adequate nodal dissection in men
treated with radical prostatectomy
A. Briganti, A. Nonis, C. Brombin, L.A. Kluth, F.K.H. Chun, S.F. Shariat, U. Capitanio, A. Gallina, A. Nini,
M. Bianchi, M. Tutolo, M. Freschi, C. Doglioni, G. Guazzoni, A. Salonia, P. Rigatti, C. Di Serio (Milan, Italy;
Hamburg, Germany; New York, United States of America)